Introduction {#Sec1}
============

Over 90 million Americans have inadequate health literacy (HL) skills, and over 110 million have limited health numeracy (HN) skills \[[@CR1]\]. Health literacy is defined as "the degree to which individuals can obtain, process, understand and communicate about health-related information needed to make informed health decisions" \[[@CR2]\]. Health numeracy is the ability to understand and use numbers in daily life, and is associated with HL but requires distinct skills such as understanding measurement, estimation, time, logic, multistep operations, and identifying which math skills need to be applied to solve problems \[[@CR3]--[@CR7]\]. Diabetes numeracy (DN) is the ability to apply HN skills to solve problems and perform self-management tasks specific to diabetes care \[[@CR8]\]. Adequate HL and DN skills are crucial in the management of diabetes, particularly for those on complex, intensive insulin therapy. While HL and DN may be related, patients with adequate HL skills may lack basic DN skills \[[@CR8]\].

Previous studies in patients with diabetes indicated that low HL and DN have been associated with worse disease knowledge, poor medication adherence, and poorer glycemic control \[[@CR9], [@CR10]\]. Most of the patients in these studies had type 2 diabetes and were not on intensive insulin regimens. To our knowledge, there are no data on the prevalence of low DN and its impact on glycemic control and diabetes self-management behaviors in patients on insulin pump therapy. In order for insulin pump therapy to be safe and effective, patients must participate in routine self-management activities that require adequate DN skills such as reading nutrition labels, estimating the carbohydrate content of food, interpreting fingerstick glucose readings, calculating insulin doses, applying carbohydrate to insulin ratios and insulin sensitivity factors, and evaluating data from their individual insulin pumps \[[@CR11]\]. Therefore, the purpose of this study is to (1) assess DN levels of patients on insulin pump therapy and (2) explore the glycemic control and diabetes self-management behaviors of patients with different DN levels on insulin pump therapy.

Methods {#Sec2}
=======

Study Design {#Sec3}
------------

This was an exploratory, observational, cross-sectional study of the DN levels of patients on insulin pump therapy and the glycemic control and self-management behaviors of patients with different DN levels.

Setting and Study Participants {#Sec4}
------------------------------

From May 2016 to November 2016, patients from one specialty endocrinology clinic within a university health system were identified weekly through clinic schedules and invited to participate during their regular clinic appointment. Participants could be included in the study if they had type 1 or type 2 diabetes, were between 18 and 80 years of age, were English speaking, and were on insulin pump therapy for at least 3 months. Exclusion criteria included a preexisting diagnosis of severe cognitive impairment, dementia, psychosis, or blindness, or a corrected visual acuity of 20/50 or worse using a Rosenbaum vision screener. Participants received compensation (a \$20 gift card) for participating in the study. The Colorado Multiple Institutional Review Board (COMIRB) through the University of Colorado Anschutz Medical Campus approved this study (protocol \#16-0195; initially approved on 3-18-2016). All procedures performed in studies involving human participants were in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants.

Study Procedures and Assessments {#Sec5}
--------------------------------

This study involved a single clinic visit for each participant. Patients were invited to participate in the study at the beginning of their routine scheduled clinic visit. Once the routine clinic visit had concluded, the participants moved to a separate room to complete a DN test and two questionnaires. The estimated time needed to complete all study requirements was 30 min, but time limits were not given.

Diabetes numeracy was assessed by administering the Diabetes Numeracy Test (DNT-15), a validated 15-item test that evaluates diabetes-related math and interpretive skills \[[@CR12]\]. The DNT-15 is composed of word problems that require basic math calculations as well as application of those skills in the daily diabetes self-management setting, such as the interpretation of insulin dosing tables and nutrition labels \[[@CR13]\]. The general guidelines for written administration of the DNT-15 were followed. All patients were given verbal instructions, a pencil, paper, and a calculator before starting the test. Patient performance on the DNT-15 was calculated as a percentage of questions answered correctly (score range: 0--100%). Missing values were considered to be incorrect responses.

Diabetes self-management activities were assessed by administering the validated Diabetes Self-Management Questionnaire (DSMQ) \[[@CR14]\]. The DSMQ asked the participant to rate their self-management through descriptive choices, and numbers were assigned to each description, where 1 = applies to me very much, 2 = applies to me a considerable degree, 3 = applies to me to some degree, and 4 = does not apply to me. Additional self-management behaviors were obtained from electronic medical record data from the most recent clinic visit, including frequency of self-monitoring of blood glucose, frequency of infusion set placement, frequency of bolus dosing, and utilization of the bolus dose calculation function of the pump.

Participants also completed a general diabetes questionnaire to assess socioeconomic information and self-efficacy measures, including ethnicity, highest level of education, annual household income, prior diabetes education, and satisfaction and confidence with insulin pump use.

Glycemic control was assessed using the glycosylated hemoglobin (A1C), the 30-day glucometer download, and/or the 30-day insulin pump download from that day's clinic visit. If data were not available from that day's clinic visit, the most recent data found in the patient's electronic medical record was collected. Information gathered from the glucometer and pump downloads included the 30-day average glucose, the standard deviation (SD), the percentage of glucose readings within, above, and below the target range, and the proportion of blood glucose measurements \< 3.88 mmol/L.

Additional demographic and clinical information such as age, gender, duration of diabetes, and body mass index (BMI) was collected by reviewing electronic medical records.

Study data were collected and managed using REDCap electronic data capture tools hosted at the University of Colorado \[[@CR15]\]. REDCap is a secure, web-based application designed to support data capture for research studies.

Statistical Analysis {#Sec6}
--------------------

All analysis was performed using the SAS 9.3 software package (SAS Institute, Inc., Cary, NC, USA). Descriptive statistics were calculated as the mean (SD) or median \[interquartile range (IQR)\], and the frequency and percentage were evaluated for categorical variables. Patients were categorized into two groups based on their DNT-15 scores (scores ≥ 90% and scores \< 90%). Participants in the ≥ 90% group answered 14 or 15 out of 15 questions correctly on the DNT-15 and were considered to have high or adequate DN skills. Participants in the \< 90% group answered 13 or fewer out of 15 questions correctly on the DNT-15, indicating some level of deficiency in DN skills. Patient demographics, glycemic control outcomes, and self-management behaviors of patients in the two groups were compared. The chi-square test was used for categorical variables, the Wilcoxon rank sum test was used for continuous variables, and analysis of covariance (ANOVA) was used for ordinal data. The level of significance was predefined as *p* \< 0.05. Because of the exploratory, observational nature of the study, a sample-size calculation was not performed. A sample-size of 75 was targeted based on the intention that this study would serve as a small-scale pilot study prior to a subsequent larger study.

Results {#Sec7}
=======

Demographics {#Sec8}
------------

Seventy-two participants were enrolled in the study. The average age was 52 ± 14.9 years, the average A1C was 7.7% ± 1.2% (61 mmol/mol), the duration of diabetes was 27.3 ± 14.9 years, and the duration of insulin pump use was 3.4 ± 1.3 years. Forty-two participants (58.3%) were female. Sixty-five participants (90.3%) self-identified their race as White, not Hispanic (Table [1](#Tab1){ref-type="table"}). All patients had type 1 diabetes.Table 1Patient characteristicsTotal (*n  *= 72)DNT-15 score \< 90% (*n  *= 29)DNT-15 score ≥ 90% (*n  *= 43)*p* valueGender, no. (%)0.43 Female42 (58.3)19 (65.5)23 (53.5) Male30 (41.7)10 (34.5)20 (46.5)Race, no. (%)0.88 White not Hispanic65 (90.3)26 (89.7)39 (90.7) Other7 (9.7)3 (10.3)4 (9.3)Age, years (SD)52.0 (14.9)58.3 (14.9)47.7 (13.7)0.003BMI, kg/m^2^ (SD)28.1 (5.9)29.7 (7.8)27.0 (3.8)0.06Duration of diabetes, years (SD)27.3 (14.9)29.6 (16.2)25.8 (13.9)0.29Duration of pump use, years (SD)3.4 (1.3)3.2 (1.1)3.5 (1.4)0.34Education level, no. (%) College degree or higher46 (63.9)12 (41.4)34 (79.1) High school graduate/equivalent24 (33.3)15 (51.7)9 (20.9) 12th grade, no diploma2 (2.8)2 (6.9)0Household income, no. (%) Less than \$\$39,99913 (18.1)5 (17.2)8 (18.6) \$40,000 to \$99,99924 (33.3)9 (31.0)15 (34.9) \$100,000 or more30 (41.7)11 (37.9)19 (44.2)

DNT-15 Performance {#Sec9}
------------------

The median score on the DNT-15 was 93.3% (IQR 18.5). The average score on the DNT-15 was 87.5% (SD 18). Forty-three participants (60%) scored ≥ 90%, indicating adequate DN skills; 29 participants (40%) scored \< 90%, indicating some deficiency in DN skills. Of note, 14 participants (19%) scored \< 76%, indicating more limited DN skills. The most common questions missed on the DNT-15 related to calculating carbohydrate content from a nutrition label (18% answered incorrectly), assessing how to adjust diet based on exercise (14% answered incorrectly), calculating an insulin dose based on both carbohydrate amount and blood glucose level (19% answered incorrectly), and interpreting insulin dose titration instructions (26% answered incorrectly).

DNT-15 Score and Glucose Variables {#Sec10}
----------------------------------

Participants who scored higher on the DNT-15 had lower A1C levels (7.5% in DNT-15 scores ≥ 90% vs. 8.0% in DNT-15 scores \< 90%, *p* = 0.04, Table [2](#Tab2){ref-type="table"}). Participants with higher DNT-15 scores had more 30-day glucometer readings below goal compared to participants with lower DN scores (7.8% vs. 3.9%, *p* = 0.03).Table 2Glycemic control and DNT-15 scoresDNT-15 score \< 90% (*n * = 29)DNT-15 score ≥ 90% (*n  *= 43)*p* valueA1C, % (SD)8.0 (1.4)7.5 (0.9)0.04A1C, mmol/mol (SD)64.0 (11.2)58.0 (7.0)0.0430-day glucose average, mmol/L (SD)^a^10.9 (2.6)10.0 (2.5)0.1430-day glucose standard deviation, mmol/L (SD)^a^4.7 (1.6)4.0 (1.4)0.06Readings above goal, % (SD)^a^62.5 (19.9)55.0 (21.0)0.15Readings below goal, % (SD)^a^3.9 (4.1)7.8 (8.6)0.03Readings within goal, % (SD)^a^33.7 (18.7)37.5 (19.2)0.42^a^From 30-day glucometer or insulin pump download

DNT-15 Score and Patient Characteristics {#Sec11}
----------------------------------------

Participants who scored higher on the DNT-15 were younger than those with lower DNT-15 scores (average age 47.7 years in DNT-15 scores ≥ 90% vs. 58.3 years in DNT-15 scores \< 90%, *p* = 0.003; Table [1](#Tab1){ref-type="table"}). Participants who scored higher on the DNT-15 appeared to have a higher level of education than those who scored lower, but statistical analysis was not performed due to the small sample size. No significant trends between groups were found in regards to race, BMI, or household income.

DNT-15 Score and Pump-Related Self-Management Behaviors {#Sec12}
-------------------------------------------------------

The analysis of pump-related self-management behaviors and DNT-15 score showed that participants with higher DN scores were associated with more frequent use of average manual boluses per day (2.3 per day in DNT-15 score ≥ 90% group vs. 0.6 per day in DNT-15 score \< 90%, *p* = 0.03) (Table [3](#Tab3){ref-type="table"}). There were no other significant differences in pump-related behaviors between groups.Table 3Pump-related self-management behaviors and DNT-15 scoresDNT-15 score \< 90% (*n * = 29)DNT-15 score ≥ 90% (*n  *= 43)*p* valueAverage manual boluses per day0.6 (1.1)2.3 (3.3)0.04Average bolus wizard events per day4.8 (1.9)4.2 (2.6)0.40Percent of boluses overridden18.9 (22.4)24.1 (26.7)0.50Percent of boluses with correction67.8 (23.9)64.4 (21.4)0.62Average number of target glucose settings2.1 (0.9)1.9 (0.9)0.68Average number of basal settings4.7 (1.6)4.5 (1.7)0.72Average number of correction factor settings2.2 (1.5)2.6 (3.2)0.48Average number of C:I ratio settings2.5 (1.1)2.4 (1.1)0.59Average blood glucose readings per day4.1 (1.5)4.6 (4.5)0.6Average frequency of infusion set placement, days3.8 (0.9)3.8 (0.6)0.91

DNT-15 Score and Self-Management Behaviors {#Sec13}
------------------------------------------

The analysis of the DSMQ and DNT-15 scores showed that patients with lower DN scores associated more personal responsibility with the statement "My diabetes self-care is poor" (DNT-15 \< 90% 3.24 vs DNT-15 ≥ 90% 3.65, *p* = 0.04). Patients with lower DN scores also associated more with the statements "I avoid physical activity, although it would improve my diabetes" (DNT-15 \< 90% 3.14 vs DNT-15 ≥ 90% 3.65, *p* = 0.01) and "I tend to skip planned physical activity" (DNT-15 \< 90% 3.33 vs. DNT-15 ≥ 90% 3.74, *p* = 0.01). All other analyses of DSMQ and DNT-15 score showed no significant differences between groups (Table [4](#Tab4){ref-type="table"}).Table 4Diabetes self-management questionnaire (DSMQ) results and DNT-15 scoresDNT-15 score \< 90% (*n * = 29), score (SD)DNT-15 score ≥ 90% (*n  *= 43), score (SD)*p* valueI check my blood sugar levels with care and attention1.48 (0.63)1.5 (0.63)0.91The food I choose to eat makes it easy to achieve optimal blood sugar levels2.24 (0.74)2.30 (0.76)0.74I keep all doctors' appointments recommended for my diabetes treatment1.14 (0.44)1.19 (0.54)0.69I take my diabetes medications (e.g., insulin boluses) as prescribed1.17 (0.38)1.07 (0.26)0.19Occasionally I eat lots of sweets or other foods rich in carbohydrates2.86 (0.76)2.58 (0.75)0.14I record my blood sugar levels regularly2.39 (1.17)2.21 (1.17)0.52I tend to avoid diabetes-related doctors' appointments4 (0)3.98 (0.15)0.42I do regular physical activity to achieve optimal blood sugar levels2.46 (1.07)2.49 (0.85)0.92I strictly follow the dietary recommendations given by my doctor or diabetes specialist2.24 (0.83)2.47 (0.73)0.23I do not check my blood sugar levels frequently enough as would be required for achieving good blood glucose control.3.59 (0.82)3.51 (0.69)0.68I avoid physical activity, although it would improve my diabetes3.14 (0.88)3.65 (0.68)0.01I tend to forget to take or skip my diabetes medications (e.g., insulin boluses)3.55 (0.74)3.70 (0.46)0.31Sometimes I have real "food binges" (not triggered by hypoglycemia)3.34 (0.86)3.37 (0.75)0.89Regarding my diabetes care, I should see my medical provider more often3.62 (0.68)3.61 (0.69)0.95I tend to skip planned physical activity3.33 (0.78)3.74 (0.49)0.01My diabetes self-care is poor3.24 (0.99)3.65 (0.64)0.04Scores are averages based on a four-point scale where 1 = applies to me very much; 2 = applies to me a considerable degree; 3 = applies to me to some degree; 4 = does not apply to me

DNT-15 Score and Self-Efficacy {#Sec14}
------------------------------

On a scale from 0 to 100, with 100 being fully confident, there was no significant difference between groups when participants were asked about their general level of confidence in managing diabetes with an insulin pump (86 in participants with DNT-15 score ≥ 90% vs. 84 in participants with DNT-15 score \< 90%, *p* = 0.49). However, when asked more specifically about pump features, participants with higher DNT-15 scores expressed more confidence in using their pump features than patients with lower DNT-15 scores (87 vs. 75, *p* = 0.02). There was also no significant difference between groups in participant ratings of insulin pump satisfaction, self-perceived understanding of how to use their insulin pump, or receipt of sufficient insulin pump training from a diabetes educator.

Discussion {#Sec15}
==========

This study suggests that many patients on insulin pump therapy managed at a single specialty endocrinology clinic had some deficiency in DN skills. Although the median and mean DNT-15 scores were both reasonably high (93.3% and 87.5%, respectively), deficiencies in DN were still present. In addition, 19% of our patient population achieved a score of \< 76%, indicating limited DN skills, which could have significant implications for the way in which they manage their insulin pump therapy. Importantly, almost one in five patients were unable to calculate the carbohydrate content of a food item when given a nutrition label---a task that insulin pump users should perform daily. Also, approximately one in five patients could not calculate an insulin bolus dose accounting for both carbohydrate intake and glucose level. This highlights a concern that some patients may be relying solely on the pump's bolus dose calculator and are unable to perform dose calculations independently.

The occurrence and severity of low DN does seem to be better in our patient population compared to other studied populations. In a study conducted by Cavanaugh et al., the median DNT-15 score was 65% in a population of patients with type 1 or type 2 diabetes in either a primary care or diabetes clinic, which was significantly lower than the median DNT-15 score of 93.3% in our study population \[[@CR10]\]. This may be because our population was solely in a single, specialty endocrinology clinic and included patients with type 1 diabetes. In a study conducted by Zaugg et al., patients who received care from a specialist at a diabetes center had higher DN levels than patients who received care from a primary care provider, and patients with type 1 diabetes had higher DN levels compared to patients with type 2 diabetes \[[@CR16]\].

This study also suggests that low diabetes-related DN skills may be associated with poorer glycemic control, as well as some worse perceived self-efficacy and self-management behaviors in patients on insulin pump therapy. Our findings are generally consistent with other studies that have shown similar associations in patients with diabetes \[[@CR8], [@CR10], [@CR17]\], but, to our knowledge, our study is the first look into this potential association in patients specifically on insulin pump therapy.

Although one might speculate that patients with low DN would use an insulin pump differently than those with higher DN, we did not see trends indicating differences in pump-related self-management behaviors between DN groups. One interesting finding was that participants with high DN had greater use of manual boluses, which may indicate more comfort with performing dose calculations without the help of the pump's bolus dose calculator.

This study also found that individuals who scored lower on the DNT-15 were older. Similar studies have associated lower DN levels with age \[[@CR8], [@CR10]\], indicating that as patients grow older their ability to effectively manage their diabetes may diminish. Additionally, older patients may pay less attention to serving size, thereby decreasing the accuracy of their nutrition calculations \[[@CR18]\], which could increase the risk of administering an incorrect dose of insulin. Older patients are also at an increased risk of cognitive dysfunction \[[@CR19]\], and are more likely to report worse adherence to diabetes care \[[@CR20]\]. Providers should recognize the impact that age may have on DN skills, diabetes self-management, and effective insulin pump use.

There are several limitations of our study. First, conducting the study at a single, academic, specialty endocrinology clinic limits the diversity of our patient population, so the findings may not be generalizable to a larger population. Several studies have indicated that low education level and minority populations have been associated with lower DN levels and poorer glycemic control \[[@CR8], [@CR21]\], but these populations were not well represented in this study. Of note, even though the participants in our study had high education levels, were mostly White, not Hispanic, and were generally well-managed patients under a high level of specialized care, low DN was still identified. This suggests that DN is a widespread issue that affects more than minority or underserved populations. Second, this study was designed as an exploratory, observational, cross-sectional survey that was performed to initially explore possible relationships, so no conclusions on causation can be made. Our study also had a small sample size, which limits the statistical analysis. Additionally, the DNT-15 includes several questions geared towards a more general diabetes population (e.g., those on insulin injections or oral medications), which could limit the validity of the tool in our patient population. Last, there was limited availability of self-management data based on the download capability of the insulin pump type and brand.

Our study reinforces the need to identify and address DN in the diabetes population. Health literacy and numeracy focused interventions and communication strategies have been developed for a more generalized diabetes population and have been shown to improve self-efficacy and diabetes self-management behaviors \[[@CR22]--[@CR26]\]. Such strategies should also be considered in patients on insulin pump therapy.

Adequate DN skills are crucial to patients' ability to process and act on data related to their insulin pump \[[@CR11]\]. These requirements will expand as insulin pump technology continues to advance and with the incorporation of continuous glucose monitoring.

Although most patients on insulin pump therapy receive extensive education and training on numeracy-related topics, it is unknown how effective this education is or if the education is delivered at an appropriate level to ensure proper use. Currently, educational materials provided to patients with diabetes are lacking in readability, especially in relation to numeracy \[[@CR27]\]. For example, the education workbooks provided by the three most common insulin pump manufacturers require numeracy skills well above the average adult to understand their content \[[@CR28]\]. DN skills should be assessed in all patients on insulin pump therapy, and education should be delivered at an appropriate level to ensure safe and effective use \[[@CR17], [@CR27], [@CR28]\]. Further research is needed on the relationships between DN and the safety and efficacy of insulin pump usage.

Conclusion {#Sec16}
==========

Deficiencies in DN skills are present in patients on insulin pump therapy, even with a high level of care in a specialty endocrinology clinic. This study suggests that some patients with diabetes on insulin pump therapy cannot complete DN self-management tasks such as counting carbohydrates or determining appropriate insulin dosing. In this study, participants with lower DN scores had higher A1C levels, were older, were more likely to describe their diabetes self-care as poor, and had less confidence in their ability to use the features of their insulin pump. Further research in larger, more diverse populations is needed to determine DN skills in patients on insulin pump therapy and to identify possible associations with patient characteristics, glycemic control, and self-management behaviors.
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